General Information of This Linker
Linker ID
LIN0TQYGO
Linker Name
WO2024020536A1+HER-E-49+Linker
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C27H35N5O8
Isosmiles
O=C(N1CCCCCC(NCC(NCC(N[C@H](C(NCCCC(O)=O)=O)CC2=CC=CC=C2)=O)=O)=O)C=CC1=O
InChI
InChI=1S/C27H35N5O8/c33-21(10-5-2-6-15-32-24(36)12-13-25(32)37)29-17-22(34)30-18-23(35)31-20(16-19-8-3-1-4-9-19)27(40)28-14-7-11-26(38)39/h1,3-4,8-9,12-13,20H,2,5-7,10-11,14-18H2,(H,28,40)(H,29,33)(H,30,34)(H,31,35)(H,38,39)/t20-/m0/s1
InChIKey
ZQOWXYHNMQFZAX-FQEVSTJZSA-N
Pharmaceutical Properties
Molecule Weight
557.604
Polar area
191.08
Complexity
1038.515346
xlogp Value
-0.5873
Heavy Count
40
Rot Bonds
18
Hbond acc
7
Hbond Donor
5
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
HER-E-49 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
. pM
High HER2 expression (HER2 +++)
Method Description
A Cell line test on SKBR-3
In Vitro Model Breast adenocarcinoma SK-BR-3 cells CVCL_0033
References
Ref 1 Hexacyclic topoisomerase inhibitors having cytotoxic activity on cancer cells